Specifically designed for the purpose of Adenoviral vector production, CEVEC’s proprietary CAP®Ad Platform based on human suspension cells is the ideal production platform for the manufacturing of RCA-free Adenoviral vectors from research up to industrial scale.
VIRAL VECTORS AND VACCINES
CELL LINES FOR
MOVE TO AN
RCA-FREE ADENOVIRUS PRODUCTION PROCESS
RIGHT FROM THE START
HUMAN CELL LINE
Non-tumor cell line derived from human amniocytes
Complete documentation of cell line development and full certification of materials
Suspension cell line growing at high cell densities for high yields
GMP MCB tested according to ICH guidelines and WHO recommendations. Biologics Master File on file at U.S. FDA
In addition to Adenoviral vectors, CAP® cells have also proven to be an efficient host cell line for the production of viral vaccines, Lentiviral vectors, Oncolytic viruses, and Exosomes.